Demand for COVID-tests (account for nearly 50% of its total revenue) will continue with the lower vaccination rate in its operating countries and increasing incoming foreign tourists.
Increasing contribution from high-value house calls, walk-in patients, and radiology services should act as margin drivers for the company, amid recovery of conventional test revenue at IDH.